The Hidden Challenge Parents Don't Always See
Imagine your teenager is finally on a breakthrough medication that could transform their health. The drug works beautifully—lung function improves, breathing becomes easier. Yet something invisible is happening: depression is creeping in, making it harder for them to take their medications consistently, and quietly sabotaging the very treatment that could help them thrive.
This is the reality for many Singapore teens with cystic fibrosis (CF), according to new research from Frontiers in Pediatrics. Scientists studied 34 young people aged 12–21 taking Elexacaftor/Tezacaftor/Ivacaftor (ETI)—a powerful new medication that's transforming CF care worldwide. What they discovered should matter to every parent: mental health and physical health are deeply intertwined, and we can't treat one without addressing the other.
What the Research Found
The numbers are striking. Nearly half of the teens studied (44%) screened positive for depressive symptoms. This isn't just sadness—it's a clinical concern that significantly affected how consistently they took their medication.
Here's what happened: While the medication itself worked brilliantly at first, teenagers who were struggling with depression showed a troubling pattern over time. Their sweat chloride levels (a key marker of how well the medication is controlling their CF) became increasingly unstable. Their medication possession ratio—basically, a measure of whether they're picking up prescriptions on schedule—dropped from 0.95 to 0.75. That's a real decline in adherence.
Interestingly, lung function improvements held steady in both groups, suggesting that the medication's physical benefits were robust. But the emotional and behavioural patterns told a different story: depression was creating invisible friction in daily treatment routines.
Why This Matters for Singapore and Asian Families
In Singapore and across Asia, we often prioritize physical health achievements while staying quieter about mental wellbeing. For parents of teens with chronic conditions like CF, this can mean celebrating medical breakthroughs while missing the psychological toll that chronic illness—and even successful treatment—can place on young people.
Depression in teens with CF isn't a character flaw or laziness. It's a real medical condition that needs real attention. When it goes unnoticed, even life-changing medications can't work at their full potential. This research suggests that structured mental health screening should be just as routine as blood tests and lung function checks.
What You Can Do Right Now
- Screen for depression regularly, not just at annual check-ups. Ask your teen's CF team to use simple screening tools like the PHQ-9 (the same tool used in this study) at every clinic visit. Watch for signs like persistent low mood, loss of interest in activities, sleep changes, or difficulty concentrating—these are just as medical as any physical symptom.
- Connect medication adherence directly to their feelings. If your teen's medication possession ratio or treatment consistency is slipping, ask gently: "How are you feeling about taking this medication? What's making it hard?" Often the barrier isn't forgetfulness—it's emotional resistance that needs naming and addressing with proper support.
- Build a team that treats the whole person. Work with your CF team to include a psychologist or counsellor who understands chronic illness. Mental health support isn't an add-on for "problem kids"—it's essential preventative care for any teenager managing a complex condition.
Your teen's cystic fibrosis is real, and their depression is equally real. The good news? When both are recognized and treated together, young people can truly thrive.